Ensemble Discovery Corp.
This article was originally published in Start Up
Ensemble Discovery Corp. is developing a breakthrough system for assembling and discovering new molecular entities. The company's proprietary technology, DNA-Programmed Chemistry, can quickly synthesize molecules that are intractable to traditional synthesis techniques as well as identify and purify novel molecules with desired properties.
You may also be interested in...
Analyzing the venture financings closed by 2004's new crop of biotech, diagnostics, and medical device start-ups reveals today's trends that may shape tomorrow's health care industry. Here we point out eleven 2004 Series A financings that identify and illustrate what's hot.
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.